This inventor holds 14 USPTO granted patents, plus 1 CIPO patent and 3 EPO patents. Top assignees: Merck Sharp + Dohme Corp., Novartis Ag, Merck + Co., Inc.. Active years: 2006-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Bishops Stortford, GB (2007 - 2008)
- Bishop Stortford, GB (2008)
- South Benfleet, GB (2006 - 2009)
- Horsham, GB (2011 - 2017)
Company Filing History:
9 out of 2,405 
5 out of 3,975 
1 out of 4,770 
Years Active: 2006-2017
Title: The Inventor Extraordinaire: Paul Joseph Oakley
Introduction: Paul Joseph Oakley is a prolific inventor hailing from South Benfleet, Great Britain. With an impressive portfolio of 14 patents under his belt, he has made significant contributions to the field of medicine and pharmaceuticals.
Latest Patents: Among his latest patents is the groundbreaking work on "Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives." This revolutionary compound has shown great promise in treating diseases that respond to the blockade of the epithelial sodium channel. The pharmaceutical compositions containing these compounds, as well as the processes for their preparation, have been detailed in his patents.
Career Highlights: Oakley has lent his expertise to renowned companies such as Merck Sharp & Dohme Corporation and Novartis AG. His innovative spirit and dedication to scientific advancements have propelled him to the forefront of the pharmaceutical industry.
Collaborations: Throughout his career, Oakley has had the privilege of collaborating with esteemed professionals in the field. Notable coworkers include Martin Richard Teall and Timothy Harrison, who have worked alongside Oakley in bringing cutting-edge inventions to life.
Conclusion: Paul Joseph Oakley stands as a testament to the power of innovation and dedication in the world of patents and inventions. His relentless pursuit of scientific excellence has left an indelible mark on the industry, and his contributions continue to shape the future of medicine and pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile